Results for:(171 found)
Nov 7, 2012 12:15PM on Top StocksBy Minyanville.com

The pharma wins US approval for a new rheumatoid arthritis pill, but Abbott's existing treatment isn't likely to suffer a meaningful hit to sales anytime soon.

Oct 31, 2012 12:10PM on Top StocksBy TheStreet Staff

The second-generation HIV drug is being developed to counteract expiring patents.

Oct 23, 2012 11:56AM on Top StocksBy Stock Traders Daily

The pharma's earnings may not look great, but bailing out could prove costly for investors if its Alzheimer's drug is successful.

Oct 2, 2012 10:55AM on Top StocksBy TheStockAdvisors

These solid, dividend-paying stocks are well-suited to a buy-and-hold strategy.

Oct 1, 2012 9:58AM on Top StocksBy InvestorPlace

Revenue per employee is one way to measure a company's efficiency. Based on that, the energy giant tops the mega-caps.

Sep 28, 2012 11:22AM on Top StocksBy MSN Money Partner

Research In Motion is upgraded to 'sector perform,' and Pfizer is initiated with an 'outperform.'

Sep 17, 2012 3:03PM on Top StocksBy Benzinga

The company's listing status might not mean much, as new additions do not always see great success.

Sep 7, 2012 8:24AM on Top StocksBy Melly Alazraki

US nonfarm payrolls rose a weak 96,000 in August. The unemployment rate fell to 8.1%. Intel lowers its Q3 revenue outlook.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

How to invest when the world is in chaos

As geopolitical tensions threaten to spin out of control, investors are wondering how best to position their portfolios for the global turmoil.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More